Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

Testing a Solution: Stem Cell-Derived CAR T Cells . In their study, researchers Wang et al. sought to grow a universal source of cytotoxic T cells to use in cell therapies such as CAR T.

CAR T cell therapy is a promising approach to treatment that might have the potential to put lupus into remission for long periods for some patients. However, it is very early in the research process ...

RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers ...

Engineering CAR-T cells to activate small-molecule drugs in situ. Nature Chemical Biology, 2021; DOI: 10.1038/s41589-021-00932-1; Cite This Page: MLA; APA; Chicago; Memorial Sloan Kettering Cancer ...

Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T ...

If you have CAR T-cell therapy, your doctor will monitor you for about 2 to 3 months afterward while you recover. You'll be checked often for side effects and to see if the treatment is helping.

Olfactory Receptor OR2H1 is an effective target for CAR T cells in human epithelial tumors. Molecular Cancer Therapeutics, 2022; DOI: 10.1158/1535-7163.MCT-21-0872; Cite This Page: MLA; APA; ...

A novel autologous CAR-T therapy, YTB323, with preserved t-cell stemness shows enhanced CAR T-cell efficacy in preclinical and early clinical development. Cancer Discov 2023;13:1982-1997. Crossref ...